New cancer drugs are very expensive – heres how we work out value for our money
By Jonathan Karnon, Hossein Haji Ali Afzali, Laura C Edney
9 Sep 2015
The Senate Standing Committee on Community Affairs is expected to table its report on the “Availability of new, innovative and specialist cancer drugs in Australia” today. Initiated by South Australian senator Nick Xenophon, the inquiry, which was initially slated to report in late March, is focusing on timely access and affordability of cancer drugs, and ...